Allied Market Research

2024

Nasal Drug Delivery Technologies Market

Nasal Drug Delivery Technologies Market Size, Share, Competitive Landscape and Trend Analysis Report by Dosage Form, by Container, by System, by Therapeutic Applications and by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Nasal delivery is used as a treatment of local infection in the nasal course & paranasal sinuses such as allergic & non-allergic sinusitis & rhinitis. The nasal drug delivery technique is used as to mitigate the problem of slow absorption of drugs, degradation before reaching the target site, and poor bioavailability. In addition, it helps in resolving issues related to the gastrointestinal tract and first-pass metabolism in liver. The significance of the nasal airway technology is to protect the lungs from hazardous contacts, rather than acting as a delivery route for drugs.

The global nasal drug delivery technology market is driven by rise in demand for alternative routes of drug delivery such as nasal sprays, increase in emphasis on pediatric & geriatric patients, growth in need of easy administration & better efficacy products, rise in demand for home healthcare devices, surge in adoption of self-administration practices, and advanced healthcare set-up. However, patents expiry of several drugs and side effects pertaining to drugs, such as nausea, irritation, and infections, restrain the market growth. Conversely, the development of OTC drugs by many pharmaceutical companies provides lucrative opportunities for market growth, especially for nasal drops and sprays sold as generic OTC drugs.

The global nasal drug delivery technology market is segmented on the basis of dosage form, container, system, therapeutic application, end user, and region. Based on dosage form, it is categorized into sprays, drops & liquids, powders, gels, and others. On the basis of container, it is bifurcated into pressurized containers and non-pressurized containers. Based on system, it is divided into multi-dose systems, bi-dose systems, and unit-dose systems. Based on therapeutic application, it is classified into allergic & non-allergic rhinitis, nose congestion, vaccination, and others. Based on end user, it is divided into home care settings and hospitals. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players operating in this market include Merck & Co., Inc., Novartis AG, Johnson & Johnson, Pfizer Inc., AstraZeneca, AptarGroup, Inc., GlaxoSmithKline plc., Aegis Therapeutics LLC., and Becton, Dickinson and Company.

Key Benefits

  • The report presents the market analysis of the global nasal drug delivery technology market along with the regional trends and future estimations.
  • It provides extensive information about the market segments¬†to understand the market dynamics.
  • The key factors that drive, hamper, or provide opportunities to the market are provided in the report
  • Competitive landscape of the industry along with the profile analysis of market players is provided in the report.

Nasal Drug Delivery Technologies Market Report Highlights

Aspects Details
icon_5
By Dosage Form
  • Sprays
  • Drops & Liquids
  • Powders
  • Gels
  • Others
icon_6
By Container
  • Pressurized Containers
  • Non-pressurized Containers
icon_7
By System
  • Multi-dose Systems
  • Bi-dose Systems
  • Unit-dose Systems
icon_8
By Therapeutic Applications
  • Allergic & Non-allergic Rhinitis
  • Nose Congestion
  • Vaccination
  • Others
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_10
By End User
  • Home Care Settings
  • Hospitals
icon_11
Key Market Players

Becton, Dickinson and Company., Merck & Co., Inc., GlaxoSmithKline plc., Aegis Therapeutics LLC., Johnson & Johnson, AstraZeneca, AptarGroup, Inc., Novartis AG, Pfizer Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Nasal Drug Delivery Technologies Market

Global Opportunity Analysis and Industry Forecast, 2023-2032